Condensed Consolidated Statements of Stockholders’ Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Feb. 05, 2023		304,076
Beginning balance at Feb. 05, 2023	$ 941,233	$ 30	$ 2,493,769	$ (15,504)	$ (1,537,062)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		3,711
Issuance of common stock upon exercise of stock options	32,878		32,878
Stock-based compensation expense	259,189		259,189
Vesting of restricted stock units (in shares)		10,613
Vesting of restricted stock units	0	$ 2	(2)
Tax withholding on vesting of restricted stock units (in shares)		(546)
Tax withholding on vesting of restricted stock units	(16,582)		(16,582)
Common stock issued under employee stock purchase plan (in shares)		2,233
Common stock issued under employee stock purchase plan	45,089		45,089
Repurchase of common stock (in shares)		(4,102)
Repurchases of common stock	(114,341)		(114,341)
Issuance of common stock upon conversion of convertible senior notes (in shares)		1
Issuance of common stock upon conversion of convertible senior notes	(356)		(356)
Other comprehensive income (loss)	5,472			5,472
Net income (loss)	(4,127)				(4,127)
Ending balance (in shares) at Nov. 05, 2023		315,986
Ending balance at Nov. 05, 2023	1,148,455	$ 32	2,699,644	(10,032)	(1,541,189)
Beginning balance (in shares) at Aug. 06, 2023		311,839
Beginning balance at Aug. 06, 2023	986,328	$ 31	2,610,482	(12,607)	(1,611,578)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		311
Issuance of common stock upon exercise of stock options	2,996		2,996
Stock-based compensation expense	89,512		89,512
Vesting of restricted stock units (in shares)		3,438
Vesting of restricted stock units	0	$ 1	(1)
Tax withholding on vesting of restricted stock units (in shares)		(131)
Tax withholding on vesting of restricted stock units	(4,755)		(4,755)
Common stock issued under employee stock purchase plan (in shares)		1,164
Common stock issued under employee stock purchase plan	23,870		23,870
Repurchase of common stock (in shares)		(635)
Repurchases of common stock	(22,460)		(22,460)
Other comprehensive income (loss)	2,575			2,575
Net income (loss)	70,389				70,389
Ending balance (in shares) at Nov. 05, 2023		315,986
Ending balance at Nov. 05, 2023	1,148,455	$ 32	2,699,644	(10,032)	(1,541,189)
Beginning balance (in shares) at Feb. 04, 2024		319,523
Beginning balance at Feb. 04, 2024	1,270,094	$ 32	2,749,595	(3,782)	(1,475,751)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		1,656
Issuance of common stock upon exercise of stock options	20,932		20,932
Stock-based compensation expense	324,735		324,735
Vesting of restricted stock units (in shares)		9,643
Vesting of restricted stock units	$ 0	$ 1	(1)
Tax withholding on vesting of restricted stock units (in shares)	(2,500)	(2,478)
Tax withholding on vesting of restricted stock units	$ (144,022)		(144,022)
Common stock issued under employee stock purchase plan (in shares)		2,388
Common stock issued under employee stock purchase plan	51,736		51,736
Repurchase of common stock (in shares)		(3,600)
Repurchases of common stock	(181,998)		(181,998)
Other comprehensive income (loss)	4,805			4,805
Net income (loss)	64,304				64,304
Ending balance (in shares) at Nov. 03, 2024		327,132
Ending balance at Nov. 03, 2024	1,410,586	$ 33	2,820,977	1,023	(1,411,447)
Beginning balance (in shares) at Aug. 04, 2024		327,465
Beginning balance at Aug. 04, 2024	1,453,161	$ 33	2,925,507	2,707	(1,475,086)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		249
Issuance of common stock upon exercise of stock options	3,164		3,164
Stock-based compensation expense	103,257		103,257
Vesting of restricted stock units (in shares)		2,938
Vesting of restricted stock units	$ 0
Tax withholding on vesting of restricted stock units (in shares)	(1,100)	(1,113)
Tax withholding on vesting of restricted stock units	$ (55,361)		(55,361)
Common stock issued under employee stock purchase plan (in shares)		1,193
Common stock issued under employee stock purchase plan	26,408		26,408
Repurchase of common stock (in shares)		(3,600)
Repurchases of common stock	(181,998)		(181,998)
Other comprehensive income (loss)	(1,684)			(1,684)
Net income (loss)	63,639				63,639
Ending balance (in shares) at Nov. 03, 2024		327,132
Ending balance at Nov. 03, 2024	$ 1,410,586	$ 33	$ 2,820,977	$ 1,023	$ (1,411,447)